secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001493152-25-025182
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma files updated auditor consents for S-3 registration
-------------------------------------------------------------------

- Filed updated consents from former auditor KMJ Corbin and current auditor Crowe LLP, dated Nov 26, 2025.
- Consents relate to audit reports on FY2024 financials included in Form 10-K filed Mar 25, 2025.
- Consents are for incorporation into Registration Statement on Form S-3 (No. 333-290725).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315225025182/0001493152-25-025182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315225025182/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer